Product Information
CIPROFLOXACIN 0.3% EYE DROP is a generic product labeled by Advagen Pharma Ltd., priced at $3.0781 per ML under NDC 72888010221. Its NADAC has been published 60 times since Aug 13, 2025.
FDA first approved this application on Jun 9, 2004. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Advagen Pharma Ltd.NDC
72888010221
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075928FDA Approved
6/9/2004
TE Code
AT
On Market Since
3/16/2022
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN 0.3% EYE DROP has been published 60 times since Aug 13, 2025, and over the history we have for it it has risen 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0781 per ML |
|---|---|
| All-time high | $3.2017 (Sep 16, 2026) |
| All-time low | $2.6764 (Aug 13, 2025) |
| 52-week high | $3.2017 |
| 52-week low | $2.7946 |
| Median price | $2.8940 |
| Average price | $2.9101 |
| Largest weekly change | +8.6% (Aug 19, 2026) |
| Weeks tracked | 60 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 74% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Advagen Pharma Ltd. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CIPROFLOXACIN HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Fluoroquinolone Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN 0.3% EYE DROP, manufactured by Advagen Pharma Ltd., is $3.0781 per ML (NDC 72888010221), effective Sep 30, 2026.
How has the price of CIPROFLOXACIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has risen 15.0%. It has been tracked across 60 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN 0.3% EYE DROP?
Since Aug 13, 2025, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has ranged from a low of $2.6764 (Aug 13, 2025) to a high of $3.2017 (Sep 16, 2026), with a median of $2.8940 per ML.
Are there cheaper alternatives to CIPROFLOXACIN 0.3% EYE DROP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIPROFLOXACIN 0.3% EYE DROP, is $0.7964 per ML — about 74% below CIPROFLOXACIN 0.3% EYE DROP.
Who manufactures CIPROFLOXACIN 0.3% EYE DROP?
CIPROFLOXACIN 0.3% EYE DROP (NDC 72888010221) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.